Articles
Page 15 of 19
-
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P303
-
Do cerebral function test results correlate when measured by a computerised battery test and a memory questionnaire in HIV-1 infected subjects?
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P301 -
Results of a Phase I study to evaluate the safety, tolerability, pharmacokinetics (with and without ritonavir) and food-effect of VCH-286
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P298 -
Hospital admissions and associated diagnosis of HIV patients in the HAART era
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P296 -
Rapid rebound in hepatitis B DNA in previously undetectable hepatitis B/HIV co-infected patients switching from tenofovir to entecavir therapy
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P271 -
Switching from zidovudine/lamivudine (ZDV/LMV) to tenofovir/emtricitabine (TDF/FTC) or abacavir/lamivudine (ABC/LMV) in HIV/HCV co-infection (COTKI study)
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P267 -
A 4-year follow-up of a cohort of HIV-positive cirrhotic patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P265 -
Incidence of immune reconstitution inflammatory syndrome among HIV patients infected with tuberculosis in a Dublin cohort
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P263 -
Clinical epidemiology of HIV and tuberculosis co-infection in Galati, Romania
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P261 -
Factors associated with positive tuberculin skin test results in HIV-1 infected Thai patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P259 -
Impact of CMV infection on horizontally transmitted HIV-1 disease progression
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P257 -
Occupational HIV exposure among Thai healthcare workers: an analysis of 558 exposures during 1998–2007
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P232 -
Patient satisfaction survey for the home delivery of medication scheme
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P230 -
Prevalence and risk factors associated with loss to follow-up in a cohort of HIV-infected patients treated with highly active antiretroviral treatment
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P228 -
Materno-fetal transmission of HIV infection in Constanta county in the last 8 years
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P226 -
Particular aspects of mother-to-child transmission of HIV infection: single center's 7-year experience in Romania
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P224 -
HIV-1 pol gene diversity and antiretroviral drug resistance mutations in Itanhaém city, Brazil
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P196 -
Is HAART based on newest active antiretroviral drugs influenced by GSS?
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P194 -
Genotypic susceptibility to tipranavir (TPV) and darunavir (DRV) in a cohort of treatment-experienced patients (TEP)
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P192 -
Incidence of the resistance mutation K65R on reverse transcriptase in different HIV-1 subtypes
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P188 -
Clinical concentrations of efavirenz (EFV) reduce cellular proliferation and viability in several human cell lines
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P161 -
Quality of life of HIV-infected individuals in a community-based antiretroviral programme
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P159 -
Safety analysis of darunavir/r (DRV/r): combined data from randomised Phase II and Phase III studies
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P157 -
CNA110329: a prospective epidemiological study to determine the prevalence of HLA-B*5701 in HIV-1 infected individuals in five European countries
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P155 -
Correlates of spinal deforming index (SDI) in HIV-positive patients naive and on treatment
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P153 -
Sensory neuropathy not associated with interruption of ARV therapy in taking stavudine-lamivudine-nevirapine combination HAART in Abuja, Nigeria
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P149 -
A 24-month follow-up of the metabolic profile of Greek HIV (+) population on lopinavir/ritonavir-based regimen: the ACA GREC trial
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P124 -
Lipometabolic side-effects of three ritonavir-boosted double protease inhibitor regimens without reverse transcriptase inhibitors
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P122 -
Efavirenz induces alterations in lipid metabolism through AMPK activation
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P120 -
Biochemical markers of bone turnover and calcium dietary intake evaluation in HIV-infected patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P118 -
Vitamin D deficiency in the in-patient HIV population: cause or affect?
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P116 -
Do genetic polymorphisms associated with inflammation/lipodystrophy or endothelial damage predict carotid alterations in HIV+ subjects under cART?
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P99 -
Evaluation of the impact of lopinavir/ritonavir (LPV/r) and ritonavir (RTV) on QTcF: results of a thorough QT study
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P95 -
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P70 -
Induction strategy with enfuvirtide: results from the Fuziona study, a multicenter retrospective study in Spain
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P64 -
Does HIV-1 tropism change in patients during virological suppressive therapy?
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P62 -
Efficacy and safety of switching enfuvirtide to raltegravir in patients with viral suppression
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P58 -
Raltegravir therapy in HIV multi-experience patients: safety and efficacy
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P31 -
Reduction in AIDS defining events/deaths with etravirine (ETR; TMC125) compared to placebo: pooled DUET 48-week results
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P27 -
Antiretroviral tolerability and efficacy after switch to saquinavir in PI-experienced patients: 48-week analysis of the German Rainbow Cohort
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P25 -
O224 The early AIDS epidemic in the U.S.: views from Atlanta and Hollywood
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O23 -
Virological response with fully active etravirine (ETR; TMC125) after 48 weeks of treatment: pooled results from the DUET-1 and DUET-2 trials
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P23 -
O214 The FOTO study: 24-week results support the safety of a 2-day break on efavirenz-based antiretroviral therapy
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O19 -
Comparison of the efficacy at 48 weeks of first-line antiretroviral treatment for HIV infection in 1998 and 2006: a multicentric investigation
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P19 -
O212 Rate of change in CD4 counts in patients with stable HIV viremia
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O17 -
O134 HIV disease management and challenges in Eastern Europe and Central Asia
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O15 -
O121 Drug interactions that really matter
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O6 -
O114 NNRTI mutations are efficiently transmitted within clusters of new HIV infections
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O4 -
The implications beyond public health if we don't manage the HIV epidemic
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):K3 -
O112 Trends in transmitted HIV drug resistance among non-B subtypes in the UK
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O2